APIS PARTNERS LLP
A Budget booster shot can turn India into a global pharma powerhouse
BUDGET EXPECTATIONS: The Indian pharmaceutical industry, also known as the pharma industry, commands a significant share in the global medicine supply chain and has played a pivotal role in making India the 'Pharmacy of the World.' It is projected to reach USD 65 Bn by 2024. India ranks third in terms of volume but drops to 14th in terms of value.
Dai-ichi Life invests $40mn in RenewBuy's holding company
This is part of the company's Series D fundraise while the promoters are negotiating with a few other investors to mobilise another $10-20 million in primary deals.
Akums enters into a pact with Leiutis, Biophore for bringing therapeutics to India
This association is set to bring succour in therapy areas of CNS disorders, pain management, and hormonal disorders, where there is a gap in meeting the needs of patients in an effective, safe, and convenient manner.
You cannot keep on changing your strategy for every event that happens: Samit Vartak
“Every year you will have different worries. It could be inflation, slow growth, any random war or trade war or any of such things. The key is to stick to your strategy because this strategy must be something which works across different risk parameters and risk will keep on emerging, the world has become too volatile.”
PAG, partners buy controlling stake in Optimus for Rs 2,000 crore
PAG, a leading alternative investment firm focused on Asia-Pacific, along with consortium partners CX Partners and Samara Capital, on Wednesday said they have reached an agreement to acquire a controlling stake in Hyderabad-based pharmaceutical firm Optimus Drugs.
- Go To Page 1
Loyalty management solutions provider Giift invests Rs 225 crore in Xoxoday in equity deal
"Xoxoday will use the USD 30 million (Rs 225 crore) investment to fuel the next stage of growth in international markets and upgrade the technology infrastructure required to serve the next set of billion users," the statement said.
RenewBuy acquires fintech firm Artivatic.AI
Artivatic.AI is valued at $10 million while acquisition is done by a combination of cash payment and share-swap deals. Promoters of the AI-based start-up have received shares of RenewBuy, according to the chief executives of both the firms. The deal was closed in the first week of February.
Market movers: This microcap's foray into NFT sparks 10% rally in shares
Shares of Brightcom Group hit 5 per cent upper circuit on announcing record date for bonus issue of shares. The company decided to set March 16 as the record date.
Note to lenders: Anyone who can code well can be a banker
Finance is getting impatient in the digital age. Indians now pay and receive Rs 7.7 lakh core a month via apps running over a shared public utility. In the next few years, nearly 440 million owners of cheaper feature phones will be able to conduct cashless transactions. We are beginning to see the first stirrings of this radical overhaul. For banks in India, a fundamental rethink is required now before it’s too late.
ETtech Deals Digest: PharmEasy, Cred raise funds this week
Online pharmacy PharmEasy and credit card repayment platform Cred were among the startups that raised funds this week with a significant bump up in their valuations.
RenewBuy raises another $10 million equity, plans international foray
This comes close on the heels of a $45 million capital infusion led by Apis Partners and is part of the firm's third round of equity raising.
UK's Apis Partners and others invest $45 million in RenewBuy
This is RenewBuy's third round of equity raising. The company plans to upgrade its technology capabilities to expand its customer base 10 times to around 25 million in the next five years. Policybazaar currently has over 11 million customers.
Stocks in the news: Bandhan Bank, Voda Idea, YES Bank, IRB Infra and BPCL
BPCL has procured 500 million barrels of distress crude (five shiploads) at a discount of $3-5 per barrel.
Indian pharma cos need to focus on innovation & complex generics: Sudarshan Jain
"Open up pharma market, it will be win-win for Indian companies as well as China."
Apis takes 25% in L&T Infra Debt fund for $110 million
The company, which started operations in 2013, has no bad loans.
ICICI Lombard frontrunner for Star Health
Star Health, founded in 1996, is India’s first and largest standalone health insurance firm that was founded by V Jagannathan, the former head of public sector insurer United India Insurance.
In pharma, you always get stock specific bets: Rahul Singh, Ampersand Investment
In telecom, opportunity was there 6-9 months ago but now the telecom companies have caught up
GST Council revises rates for 66 items
"After considering the recommendations, GST Council has reduced tax rates on 66 out of 133 items on which representations were made by the industries," FM said.
Load More
